Interleukin-1β release from rat gastric fundus

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 271, Issue 2 34-2, 1996, Pages

  Montuschi, Paolo ^b   Tringali, Giuseppe ^b   Mirtella, Adriana ^b   Parente, Luca ^b   Ragazzoni, Enzo ^b   Preziosi, Paolo ^a   Navarra, Pierluigi ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

gastric acid secretion; glucocorticoids; stomach

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEROID THERAPY; STOMACH ACID SECRETION; STOMACH FUNDUS; STOMACH MUCOSA INJURY; STOMACH PH; STOMACH PROTECTION; STRESS;

EID: 0029791109     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1996.271.2.g275     Document Type: Article

References (24)

1. Bertaccini, G., R. Eanden, V. Erspamer, and M. Impicciatore. The actions of caerulein on gastric secretion of the dog and the rat. Br. J. Pharmacol. 34: 311-239, 1968.
2. Currò, D., P. Preziosi, E. Ragazzoni, and G. Ciabattoni. Peptide histidine isoleueine-like immunoreactivity release from the rat gastric fundus. Br. J. Pharmacol. 113: 541-549, 1994.
3. D'Amato, M., D. Currò, P. Montuschi, G. Ciabattoni, E. Ragazzoni, and R. A. Lefebvre. Release of vasoactive intestinal polypeptide from the rat gastric fundus. Br. J. Pharmacol. 105: 691-695, 1992.
4. Dinarello, C. A. Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652, 1991.
5. Hierlihy, L. E., J. L. Wallace, and A. V. Ferguson. Role of gastric acid secretion and blood flow in the development of vagal stimulation induced gastric mucosal damage. Can. J. Physiol. Pharmacol. 71: 829-834, 1993.
6. Mezey, E., and M. Palkovits. Localization of targets for anti-ulcer drugs in cells of the immune system. Science Wash. DC 258: 1662-1665, 1992.
7. Montuschi, P., G. Tringali, D. Currò, G. Ciabattoni, L. Parente, P. Preziosi, and P. Navarra. Evidence that interleukin-1β and tumor necrosis factor inhibit gastric fundus motility via the 5-lipoxygenase pathway. Eur. J. Pharmacol. 252: 253-260, 1994.
8. 2 activity via stimulation of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 256: 29-37, 1991.
9. Murison, R., and H. K. Bakke. The role of corticotropin-releasing factor in rat gastric ulcerogenesis. Ann. NY Acad. Sci. 597: 71-80, 1990.
10. Navarra, P., R. Del Carmine, G. Ciabattoni, M. D'Amato, E. Ragazzoni, M. Vacca, A. R. Volpe, and P. Preziosi. Hydroxyurea: relationship between toxicity and centrally-induced adrenal activation. Pharmacol. Toxicol. 67: 209-215, 1990.
11. Parente, L., and K. G. Mugridge. Glucocorticoids and gastrointestinal inflammation. In: Immunopharmacology of the Gastrointestinal System. New York: Academic, 1993, p. 169-184.
12. Perretti, M., K. G. Mugridge, J. L. Wallace, and L. Parente. Reduction of aspirin-induced gastric damage in rats by interleukin-1β: possible involvement of endogenous corticosteroids. J. Pharmacol. Exp. Ther. 261: 1238-1247, 1992.
13. Pomeau-Delille, G. Techniques Biologiques en Endocrinologie Expérimentale Chez le Rat. Paris: Masson, 1953.
14. Reinecker, H.-C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R. P. MacDermott, and A. Raedler. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94: 174-181, 1993.
15. 2 synthesis by the stomach, and retards gastric emptying. Life Sci. 48: 123-134, 1991.
16. Schultzberg, M., S. B. Svenson, A. Unden, and T. Bartfai. Interleukin-1-like immunoreactivity in peripheral tissues. J. Neurosci. Res. 18: 184-189, 1987.
17. Sutò, G., A. Kiràly, and Y. Taché. Interleukin 1β inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology 106: 1568-1575, 1994.
18. Taché, Y., and E. Saperas. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1. Ann. NY Acad. Sci. 664: 353-368, 1992.
19. Tsuji, K., A. Uehara, S. B. Santos, and M. Namiki. Endotoxin protects the gastric mucosa against ulcerogenic stimuli. Biochem. Biophys. Res. Commun. 197: 1326-1333, 1993.
20. Uehara, A., C. Setiya, Y. Takasugi, M. Namiki, and A. Arimura. Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. Am. J. Physiol. 257 (Regulatory Integrative Comp. Physiol. 26): R613-R617, 1989.
21. Vane, J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br. J. Pharmacol. 12: 344-349, 1957.
22. Wallace, J. L., and D. N. Granger. Pathogenesis of NSAID gastropathy: are neutrophils the culprits? Trends Pharmacol. Sci. 13: 129-131, 1992.
23. Wallace, J. L., C. M. Keenan, K. G. Mugridge, and L. Parente. Reduction of the severity of experimental gastric and duodenal ulceration by interleukin-1α. Eur. J. Pharmacol. 186: 279-284, 1990.
24. Youngman, K. R., P. L. Simon, G. A. West, F. Cominelli, D. Rachmilewitz, J. S. Klein, and C. Fiocchi. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 104: 749-758, 1993.